UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Baseline predictors of response and discontinuation of tumor necrosis factor-alpha blocking therapy in ankylosing spondylitis: a prospective longitudinal observational cohort study

Arthritis research & therapy, 2011-01, Vol.13 (3), p.R94-R94

2011

Volltextzugriff (PDF)

Rare genetic variants in interleukin-37 link this anti-inflammatory cytokine to the pathogenesis and treatment of gout

Annals of the rheumatic diseases, 2020-04, Vol.79 (4), p.536-544

2020

Volltextzugriff (PDF)

Crystal-proven gout patients have an increased mortality due to cardiovascular diseases, cancer, and infectious diseases especially when having tophi and/or high serum uric acid levels: a prospective cohort study

Clinical rheumatology, 2019-05, Vol.38 (5), p.1385-1391

2019

Volltextzugriff (PDF)

2015 Gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative

Annals of the Rheumatic Diseases, 2015-10, Vol.74 (10), p.1789-1798

2015

Volltextzugriff (PDF)

2015 Gout Classification Criteria: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative

Arthritis & rheumatology (Hoboken, N.J.), 2015-10, Vol.67 (10), p.2557-2568

2015

Volltextzugriff (PDF)

A systematic literature review of patient-reported outcome measures used in gout: an evaluation of their content and measurement properties

Health and quality of life outcomes, 2019-04, Vol.17 (1), p.63-63, Article 63

2019

Volltextzugriff (PDF)

Dapansutrile, an oral selective NLRP3 inflammasome inhibitor, for treatment of gout flares: an open-label, dose-adaptive, proof-of-concept, phase 2a trial

The Lancet. Rheumatology, 2020-05, Vol.2 (5), p.e270-e280

2020

Volltextzugriff (PDF)

Anakinra for the treatment of acute gout flares: a randomized, double-blind, placebo-controlled, active-comparator, non-inferiority trial

Rheumatology (Oxford, England), 2019-08, Vol.58 (8), p.1344-1352

2019

Volltextzugriff (PDF)

Gout lessons from 2018: CARES, a direct comparison of febuxostat vs allopurinol, and CANTOS, IL1 blocker for cardiovascular risk minimisation

Clinical rheumatology, 2019-01, Vol.38 (1), p.263-265

2019

Volltextzugriff (PDF)

Erosive Hand OsteoArthritis (EHOA): analysis of consecutive patients presenting with EHOA in a hospital-based rheumatology practice and its implications for an upcoming interventional study

Clinical rheumatology, 2022-06, Vol.41 (6), p.1833-1841

2022

Volltextzugriff (PDF)

Biochemical effectiveness of allopurinol and allopurinol-probenecid in previously benzbromarone-treated gout patients

Clinical rheumatology, 2007-09, Vol.26 (9), p.1459-1465

2007

Volltextzugriff (PDF)

Quality of care in gout: a clinical audit on treating to the target with urate lowering therapy in real-world gout patients

Rheumatology international, 2017-09, Vol.37 (9), p.1435-1440

2017

Volltextzugriff (PDF)

Management of hyperuricemia in gout: focus on febuxostat

Clinical interventions in aging, 2010-01, Vol.5, p.7-18

2010

Volltextzugriff (PDF)

Survey on management of gout among Dutch rheumatologists

Annals of the rheumatic diseases, 2008-07, Vol.67 (7), p.1049-1049

2008

Volltextzugriff (PDF)

Estimation of the carcinogenic risk of radiotherapy of benign diseases from shoulder to heel

Radiotherapy and oncology, 2005-09, Vol.76 (3), p.270-277

2005

Volltextzugriff (PDF)

A Monte Carlo analysis of possible cell dose enhancement effects by uranium microparticles in photon fields

Radiation protection dosimetry, 2011-02, Vol.143 (2-4), p.177-180

2011

Volltextzugriff (PDF)

New advances in the treatment of gout: review of pegloticase

Therapeutics and clinical risk management, 2010-10, Vol.6, p.543-550

2010

Volltextzugriff (PDF)

Rituximab in cryoglobulinaemic vasculitis, evidence for its effectivity: a case report and review of literature

Clinical rheumatology, 2011-02, Vol.30 (2), p.293-300

2011

Volltextzugriff (PDF)

An evidence-based assessment of the clinical significance of drug-drug interactions between disease-modifying antirheumatic drugs and non-antirheumatic drugs according to rheumatologists and pharmacists

Clinical therapeutics, 2009-08, Vol.31 (8), p.1737-1746

2009

Volltextzugriff (PDF)

Disease recurrence in localized scleroderma: a retrospective analysis of 344 patients with paediatric- or adult-onset disease

British journal of dermatology (1951), 2015-03, Vol.172 (3), p.722-728

2015

Volltextzugriff (PDF)

Atorvastatine for chronic synovitis due to massive intra-articular cholesterol monohydrate deposition in long-standing rheumatoid arthritis

Rheumatology (Oxford, England), 2006-12, Vol.45 (12), p.1577-1578

Jansen, T L Th A

2006

Volltextzugriff (PDF)

Efficacy and tolerability of urate-lowering drugs in gout: a randomised controlled trial of benzbromarone versus probenecid after failure of allopurinol

Annals of the rheumatic diseases, 2009-01, Vol.68 (1), p.51-56

2009

Volltextzugriff (PDF)

Rasburicase treatment in severe tophaceous gout: a novel therapeutic option

Clinical rheumatology, 2006-09, Vol.25 (5), p.749-752

2006

Volltextzugriff (PDF)

Dose constraints and guidance for exposure of individuals knowingly and willingly helping in the support and comfort of individuals undergoing medical exposure

Radiation protection dosimetry, 2006-06, Vol.118 (3), p.315-324

2006

Volltextzugriff (PDF)

Survey of posteroanterior chest radiography in The Netherlands: patient dose and image quality

British journal of radiology, 2003-06, Vol.76 (906), p.398-405

2003

Volltextzugriff (PDF)

1 – 25 von 391

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(344)
Mit Volltextzugriff
(314)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(259)
Life Sciences & Biomedicine
(210)
Humans
(149)
Female
(99)
Biological And Medical Sciences
(95)
Male
(92)
Medical Sciences
(80)
Middle Aged
(72)
Adult
(68)
Aged
(60)
Technology
(47)
Physical Sciences
(42)
Radiology, Nuclear Medicine & Medical Imaging
(29)
Rheumatology
(28)
Aged, 80 And Over
(26)
Pharmacology. Drug Treatments
(26)
Animals
(24)
Chemistry
(23)
Fundamental And Applied Biological Sciences. Psychology
(22)
General & Internal Medicine
(22)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Baseline predictors of response and discontinuation of tumor necrosis factor-alpha blocking therapy in ankylosing spondylitis: a prospective longitudinal observational cohort study

Rare genetic variants in interleukin-37 link this anti-inflammatory cytokine to the pathogenesis and treatment of gout

Crystal-proven gout patients have an increased mortality due to cardiovascular diseases, cancer, and infectious diseases especially when having tophi and/or high serum uric acid levels: a prospective cohort study

2015 Gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative

2015 Gout Classification Criteria: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative

A systematic literature review of patient-reported outcome measures used in gout: an evaluation of their content and measurement properties

Dapansutrile, an oral selective NLRP3 inflammasome inhibitor, for treatment of gout flares: an open-label, dose-adaptive, proof-of-concept, phase 2a trial

Anakinra for the treatment of acute gout flares: a randomized, double-blind, placebo-controlled, active-comparator, non-inferiority trial

Gout lessons from 2018: CARES, a direct comparison of febuxostat vs allopurinol, and CANTOS, IL1 blocker for cardiovascular risk minimisation

Erosive Hand OsteoArthritis (EHOA): analysis of consecutive patients presenting with EHOA in a hospital-based rheumatology practice and its implications for an upcoming interventional study

Biochemical effectiveness of allopurinol and allopurinol-probenecid in previously benzbromarone-treated gout patients

Quality of care in gout: a clinical audit on treating to the target with urate lowering therapy in real-world gout patients

Management of hyperuricemia in gout: focus on febuxostat

Survey on management of gout among Dutch rheumatologists

Estimation of the carcinogenic risk of radiotherapy of benign diseases from shoulder to heel

A Monte Carlo analysis of possible cell dose enhancement effects by uranium microparticles in photon fields

New advances in the treatment of gout: review of pegloticase

Rituximab in cryoglobulinaemic vasculitis, evidence for its effectivity: a case report and review of literature

An evidence-based assessment of the clinical significance of drug-drug interactions between disease-modifying antirheumatic drugs and non-antirheumatic drugs according to rheumatologists and pharmacists

Disease recurrence in localized scleroderma: a retrospective analysis of 344 patients with paediatric- or adult-onset disease

Atorvastatine for chronic synovitis due to massive intra-articular cholesterol monohydrate deposition in long-standing rheumatoid arthritis

Efficacy and tolerability of urate-lowering drugs in gout: a randomised controlled trial of benzbromarone versus probenecid after failure of allopurinol

Rasburicase treatment in severe tophaceous gout: a novel therapeutic option

Dose constraints and guidance for exposure of individuals knowingly and willingly helping in the support and comfort of individuals undergoing medical exposure

Survey of posteroanterior chest radiography in The Netherlands: patient dose and image quality

Suchergebnisse filtern